Does TACROLIMUS Cause Lymphoproliferative disorder? 139 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 139 reports of Lymphoproliferative disorder have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.2% of all adverse event reports for TACROLIMUS.
139
Reports of Lymphoproliferative disorder with TACROLIMUS
0.2%
of all TACROLIMUS reports
37
Deaths
55
Hospitalizations
How Dangerous Is Lymphoproliferative disorder From TACROLIMUS?
Of the 139 reports, 37 (26.6%) resulted in death, 55 (39.6%) required hospitalization, and 22 (15.8%) were considered life-threatening.
Is Lymphoproliferative disorder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 139 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Lymphoproliferative disorder?
METHOTREXATE (1,392)
INFLIXIMAB (225)
PREDNISOLONE (178)
PREDNISONE (141)
MYCOPHENOLATE MOFETIL (138)
CYCLOPHOSPHAMIDE (136)
AZATHIOPRINE (120)
ADALIMUMAB (98)
CYCLOSPORINE (98)
RITUXIMAB (96)
Which TACROLIMUS Alternatives Have Lower Lymphoproliferative disorder Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB